This activity is supported by unrestricted educational grants from Johnson & Johnson Vision and Sight Sciences.
Sponsored by: 
Evolve Medical Education LLC (Evolve) is an approved COPE administrator.
Accreditation Statement: COPE approved for .5 credit hours.
Course ID Number: 66982-AS
Activity ID Number: 119000
DISCLOSURE POLICY:
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interests relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Douglas K. Devries, OD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speakers Bureau: Allergan, Alcon, Bausch Health, Bio Tissue, Bruder, BVI Medical, EyeVance, Johnson & Johnson Vision, Kala, Ivantis, OcuSoft, Oyster Point, RySurg, Sun, TearLab, and Shire (Takeda). Share/Stockholder: RPS.
Marc Bloomenstein, OD, FAAO, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Allergan, Bausch + Lomb, Johnson & Johnson Vision, Novartis, OcuSoft, Reichert and Sun. Advisory Board: Alcon, Allergan, Bausch + Lomb, Johnson & Johnson Vision, Kala, Novartis, Sun and TearLab. Research/Grant Support: Tear Solutions.
Whitney Hauser, OD, FAAO, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon, Allergan, Bausch + Lomb, BioTissue, BlephEx, Bruder Medical, CoolDoctors, EyeVance Pharmaceuticals, Glaukos, Johnson & Johnson Vision, Kala, Lumenis, Novartis, Oculus, Paragon BioTeck, Science Based Health, Sight Sciences, Sun, TearLab, and Triad Life Sciences. Grant/Research: Glaukos. Speakers Bureau: Alcon, Allergan, BioTissue, Johnson & Johnson Vision, Lumenis, and Novartis. Stock/Shareholder: CoolDoctors.
Scott G. Hauswirth, OD, FAAO, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon, Allergan, Avedro, BioTissue/TissueTech, Dompe, EyePoint Medical, EyeVance Pharmaceuticals, Glaukos, Horizon, Kala, Novartis, NuSight Medical, Quidel, Science Based Health, Sight Sciences, and Sun. Grant/Research Support: TearRestore and TearSolutions.
Josh Johnston, OD, FAAO, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Alcon, Allergan, Avellino, BioTissue, Bruder Health, Johnson & Johnson Vision, Kala, MaxiVision, Shire, Sight Sciences, and Sun. Speakers Bureau: Alcon, Allergan, BioTissue, and Sun. Grant/Research Support: Allergan.
David Kading, OD, FAAO, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant/Advisory Board, Grant/Research/Speaker's Bureau: Alcon, Allergan, Bausch + Lomb, BioTissue, Cooper Vision, Oculus, EyeVance, EyeEco, Facebook, Oculaphire, OptoVue, Novartis, RPS, Shire, Solution Reach, Sun, TearScience, Valeant Pharmaceuticals, Valley Contax, Vistakon, VSP, Weave, Carl Zeiss Meditec, and ZeaVision.
Tim Poirier, OD, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Speakers Bureau: Johnson & Johnson Vision.
Justin Schweitzer, OD, FAAO, and/or spouse had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Aerie, Alcon, Allergan, Bausch + Lomb, EyePoint, Glaukos, Horizon Pharma, Johnson & Johnson Vision, Ocular Therapeutix, Quidel, Reichert, Sight Sciences, and Sun. Speakers Bureau: Aerie, Alcon, Allergan, Bausch + Lomb, Glaukos, and Johnson & Johnson Vision. Stock/Shareholder: Equinox.
EDITORIAL DISCLOSURES
Erin K. Fletcher, MIT, director of compliance and education; Cassandra Richards, director of education development, Evolve; and Diane Angelucci, writer, have no financial relationships with commercial interests.
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, Modern Optometry, Johnson & Johnson Vision, or Sight Sciences.
